BILL vs RGEN · rev $1.65B vs P/E 143, rev $204.1M
Bill Com Holdings Inc (BILL) versus Repligen Corporation (RGEN) — a side-by-side from cached financials, not a winner call.
Bill Com Holdings Inc (BILL) is a software - application company listed on US.
Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
Latest reported BILL revenue for 2026-06-30 was $1.65B. Net income was -$11.2M. Revenue was up 13.0% from 2025-06-30 to 2026-06-30. BILL currently screens at market cap $4.78B.
Latest reported RGEN revenue for 2026-06-30 was $204.1M. Net income was $5.0M. Revenue was up 5.1% from 2026-03-31 to 2026-06-30. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
BILL currently screens at market cap $4.78B. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
Not investment advice. Open the BILL and RGEN stock pages for the full models.
Not investment advice.